-
- Company
The international medical technology company B. Braun sold its Reutlingen subsidiary TETEC AG to the Canadian Octane Medical Group as of May 31, 2024.
B. Braun sells TETEC AG to Canadian specialists Octane Medical
TETEC specializes in regenerative medicine and has developed two products with NOVOCART, which treat cartilage damage in the knee through autologous cell cultivation. B. Braun has already been working with Octane Medical in the USA for over ten years. Now, the Canadian specialist in regenerative med…








